Just Published

Prenatal Clues to Multiple Sclerosis Risk Emerge
news

January 14, 2026

A new population study suggests multiple sclerosis risk might begin before birth, shaped by fetal growth and maternal diabetes.
JCP
Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes
Original Research

January 14, 2026

Even very low levels of opioid use in the first 2–3 weeks of buprenorphine treatment signal risk for poor outcomes.
, , , et al
Global Review Shows Mental Illness Threatens Diabetes Care
news

January 13, 2026

People with mental disorders face higher diabetes risk and poorer monitoring and treatment once diagnosed.
PCC
LSD-Induced Catatonia in an Adolescent
Case Report

January 13, 2026

A 16-year-old boy experienced catatonia associated with lysergic acid diethylamide use.
, , , et al
PCC
Treatment and Referral for AUD in Primary Care
Rounds in the General Hospital

January 13, 2026

Explore which treatments are best for your patients with alcohol use disorders and when you should refer for specialized psychological or pharmacologic interventions.
, , , et al
JCP
The Psychedelic Renaissance and Treatment-Resistant Depression with David Feifel, MD, PhD
Podcast

January 13, 2026

,

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Front of Mind News

The 400-Year-Old Shark That Can Still See

Recent Features

Image shows a syringe below a question about schizophrenia relapse prevention; The Psychiatrist.com logo appears at the bottom.
Figure: Promotional graphic announces a consensus report on Xanomeline-Trospium use in practice, highlighting JCP branding.
Figure: Flyer shows an adult cradling a newborn, promoting a University of Arizona event on mental health for women and children.
Figure shows a hand holding a vial and syringe above report title on PK of aripiprazole LAIs as described in JCP.

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals. Now featuring The JCP Podcast: conversations with experts exploring the research shaping clinical care.  

EXPLORE JCP
JCP
Video Therapy Habit Reversal Training for Body-Focused Repetitive Behaviors
Original Research

January 12, 2026

Large treatment effects and improvements across the lifespan for trichotillomania and excoriation disorder suggest this delivery format may address barriers to evidence-based care.
, , , et al
JCP
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Original Research

January 12, 2026

Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
, , , et al

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Cotard Syndrome in Schizophrenia
Case Report

January 8, 2026

A 42-year-old woman with schizophrenia and multiple prior hospitalizations presented with worsening psychosis and physical aggression toward her mother.
, ,
PCC
Kratom-Induced Psychosis
Letter to the Editor

January 8, 2026

The author comments on the complexity of substance-induced presentations, particularly those related to newly available psychoactive substances such as kratom.
CME Logo

Recent CME Institute Activities

2025 Manuscript Peer Review for Physicians Postgraduate Press, Inc. (The Journal of Clinical Psychiatry | The Primary Care Companion for CNS Disorders)

Evaluating the Old and New in Alzheimer’s Disease: Today’s Options for Improving Diagnosis and Treatment

Alzheimer’s Disease: New Paths to Treatment

Staying Up to Date in Perinatal Depression: Pathophysiology and Treatment Research

Neuropsychiatric Complications of Parkinson’s Disease Psychosis

Assessing Progress in FSHD Treatment Options: Unraveling Challenges and Measuring Outcomes

ASCP - American Society of Clinical Psychopharmacology logo

Read articles from ASCP Corner

ASCP Corner

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe